GE HealthCare Technologies’ (GEHC) Hold (C+) Rating Reiterated at Weiss Ratings

Weiss Ratings restated their hold (c+) rating on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report released on Tuesday morning,Weiss Ratings reports.

Several other analysts have also recently commented on GEHC. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research report on Thursday, September 18th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday. Barclays began coverage on GE HealthCare Technologies in a report on Monday. They set an “equal weight” rating and a $86.00 price objective for the company. Finally, Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $73.38 on Tuesday. The stock has a market cap of $33.50 billion, a PE ratio of 15.04, a price-to-earnings-growth ratio of 2.80 and a beta of 1.13. The business has a fifty day simple moving average of $74.47 and a 200-day simple moving average of $72.12. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors have recently bought and sold shares of GEHC. Dodge & Cox raised its holdings in GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. Norges Bank bought a new position in GE HealthCare Technologies during the second quarter valued at about $468,120,000. Holocene Advisors LP raised its holdings in GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after buying an additional 2,581,522 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in GE HealthCare Technologies by 49.9% during the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after buying an additional 1,711,963 shares in the last quarter. Finally, Menora Mivtachim Holdings LTD. bought a new position in GE HealthCare Technologies during the second quarter valued at about $80,755,000. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.